PCV13's dosing schedule is complex, said Dr. Poland, who helped to author a summary of the newest vaccines along with updated recommendations published earlier this year in Vaccine. ... Dr. Schaffner's recommendation for those vaccines is to write a
COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization. ... A new study provided data on the effectiveness of a fourth dose of the Pfizer-BioNTech COVID-19 vaccine.
ACP members can help combat misinformation about COVID-19 and other vaccines by sharing content through their social media platforms from ACP's new video series created in partnership with YouTube:
In addition to promoting the use of vaccines, he reminded physicians about some common errors in administration. ... Administering the vaccine every five years, as some providers mistakenly do, may actually be harmful.
The COVID-19 vaccines' protective effects against the delta and omicron variants were quantified by an analysis of 422,966 COVID-19 infections in Los Angeles County, published by MMWR on
In the U.S., three vaccines are licensed to prevent HPV infection: a bivalent vaccine (Cervarix, approved by the FDA in 2009), which protects against types 16 and 18; a quadrivalent ... We know that self-reported vaccination history for HPV, because it's
to severely compromised immune systems or a history of a severe adverse reaction to a COVID-19 vaccine and/or a component of those vaccines. ... Also, a modification to the EUA for the Pfizer-BioNTech vaccine authorized a booster dose in 16- and
https://acpinternist.org/archives/2009/04/vaccine.htm. New and expensive vaccines added to the schedule for adolescents, adults and children over the last several years have created a crisis in ... the National Vaccine Advisory Committee (NVAC), a board
Trial participants who received the Moderna vaccine still had antibodies six months after vaccination, reported a letter published by the New England Journal of Medicine on April 6. ... to the Pfizer-BioNTech and Moderna vaccines should not lead to
Whether patients who have already received a previous herpes zoster vaccine will object to additional vaccination with the new vaccine remains to be seen, especially considering the latter's two injections, ... Whether patients who have already received